TY - JOUR AU - Diez-Domingo, Javier AU - de Martino, Maurizio AU - Garcia-Sicilia Lopez, Jose AU - Zuccotti, Gian Vincenzo AU - Icardi, Giancarlo AU - Villani, Alberto AU - Moreno-Perez, David AU - Méndez Hernández, María AU - Álvarez Aldeán, Javier AU - Mateen, Ahmed Abdul AU - Enweonye, Igwebuike AU - de Rooij, Richard AU - Chandra, Richa PY - 2016 DO - 10.1016/j.ijid.2016.06.018 SN - 1201-9712 UR - http://hdl.handle.net/10668/2676 T2 - International Journal of Infectious Diseases : IJID : official publication of the International Society for Infectious Diseases AB - BACKGROUNDThis descriptive, non-comparative, phase III study evaluated the safety and tolerability of cell culture-derived (TIVc) and egg-derived (TIV) seasonal influenza vaccines in children at risk of influenza-related complications.METHODSFour... LA - en PB - Elsevier KW - Safety KW - Cell culture-derived KW - Influenza vaccine KW - At-risk children KW - Vacunas contra la Influenza KW - Niño KW - Adolescente KW - Vacunación KW - Humanos KW - Preescolar KW - Estaciones del año KW - Medical Subject Headings::Chemicals and Drugs::Complex Mixtures::Biological Agents::Vaccines::Viral Vaccines::Influenza Vaccines KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Child KW - Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Orthomyxoviridae Infections::Influenza, Human KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination KW - Medical Subject Headings::Check Tags::Male KW - Medical Subject Headings::Check Tags::Female KW - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans KW - Medical Subject Headings::Health Care::Environment and Public Health::Environment::Meteorological Concepts::Atmosphere::Climate::Seasons TI - Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications. TY - research article ER -